tolvaptan has been researched along with Body Weight in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (9.30) | 29.6817 |
| 2010's | 29 (67.44) | 24.3611 |
| 2020's | 10 (23.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S; Kurita, Y; Sato, N; Uno, S | 1 |
| de la Rosa, RE; García, AIM; García, EM; Moyano, AP; Oporto, FR; Utiel, FJB | 1 |
| Iida, H; Kaida, S; Maehira, H; Maekawa, T; Miyake, T; Mori, H; Nitta, N; Takebayashi, K; Tani, M | 1 |
| Amitani, K; Iha, H; Imura, H; Ishihara, S; Ishikawa, M; Ishizuka, A; Ito, Y; Kikuchi, A; Kobayashi, N; Maruyama, Y; Mitsuishi, T; Nakama, K; Nakamura, S; Nohara, T; Ohkuma, S; Omote, T; Sato, N; Shigihara, S; Shimizu, W; Sone, M; Takagi, K; Takahashi, N; Tokuyama, H; Yamamoto, E | 1 |
| Kojima, Y; Kudo, T; Murai, Y; Satoh, T; Uehara, K | 1 |
| Kanai, A; Kobayashi, T; Kojima, T; Sumitomo, N; Yoshiba, S | 1 |
| Horie, S; Ibuki, T; Kawano, H; Muto, S; Nakajima, K; Okada, T; Shibasaki, Y | 1 |
| Mori, T; Shinoda, R; Shinoda, Y; Yoshimura, T | 1 |
| Enomoto, N; Gotou, T; Hayashi, T; Higuchi, M; Itakura, J; Izumi, N; Komiyama, Y; Kubota, Y; Kurosaki, M; Nakanishi, H; Oh, W; Okada, M; Takada, H; Takahashi, Y; Takaura, K; Tamaki, N; Yasui, Y | 1 |
| Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M | 1 |
| Egashira, H; Hidaka, H; Ichita, C; Kako, M; Koizumi, K; Masuda, S; Nakayama, T; Sasaki, A; Sung, JH; Tokoro, S; Uojima, H | 1 |
| Fei, YH; Han, XB; Liu, YH; Xu, HT | 1 |
| Chen, CW; Chen, YX; Cheng, J; Ding, HG; Han, T; Mao, Q; Mao, YM; Niu, JQ; Tang, JT; Wang, MR; Wang, YF; Wang, ZH; Wei, Z; Xie, Q; Yang, YP; Ye, WJ; Zeng, M | 1 |
| Fujiwara, Y; Harada, S; Kishimoto, S; Kishimoto, Y; Kurashiki, T; Nakamura, Y; Nishimura, M; Onohara, T | 1 |
| Choi, HY; Ha, SK; Han, SW; Jeong, KH; Kang, KP; Kim, GH; Kim, HJ; Kim, HY; Kim, SW; Kim, YW; Shin, SK; Yi, JH | 1 |
| Kodama, K; Kogiso, T; Sagawa, T; Taniai, M; Tokushige, K | 1 |
| Dittrich, S; Habash, S; Kerling, A; Moosmann, J; Müller, H; Rüffer, A; Toka, O; Weiss, C | 1 |
| Gao, WQ; Meng, XD; Sun, Z | 1 |
| Akamatsu, N; Arita, J; Hasegawa, K; Ishizawa, T; Kaneko, J; Kiritani, S; Kokudo, N; Matsumura, M; Miyata, Y; Tamura, S | 1 |
| Hidaka, H; Kako, M; Koizumi, W; Kubota, K; Nakazawa, T; Shibuya, A; Sung, JH; Tanaka, Y; Uojima, H; Wada, N | 1 |
| Bellos, I; Kontzoglou, K; Perrea, DN | 1 |
| Kobayashi, T; Komatsu, M; Komorizono, Y; Okada, M; Okita, K; Sakai, T; Sakaida, I; Yamashita, S | 1 |
| Cao, Y; Deng, S; Huang, J; Huang, Y; Qian, J; Rong, S; Tan, J; Wang, C; Xiong, B; Yao, Y; Zou, Y | 1 |
| Inukai, S; Ito, K; Kato, T; Nagasaki, R; Saitoh, S; Sato, N; Sugiura, T; Suzuki, K | 1 |
| Adachi, O; Akiyama, M; Fujiwara, H; Kanda, K; Katahira, S; Kawamoto, S; Kawatsu, S; Kumagai, K; Saiki, Y; Sakatsume, K; Suzuki, T; Takahara, S | 1 |
| Al-Mohammad, A; Alskaf, E; Tridente, A | 1 |
| Nakajima, K; Sakaida, I; Shibasaki, Y; Tachikawa, S; Terai, S; Tsubouchi, H | 1 |
| Iwahasi, T; Iwahori, A; Iwasaki, T; Koizumi, N; Maruno, K; Matsuyama, K; Nishibe, T; Ogino, H; Takahashi, S; Toguchi, K | 1 |
| Doi, A; Hanatani, A; Iwata, S; Kitada, R; Matsumura, Y; Shibata, A; Sugioka, K; Takagi, M; Yoshiyama, M | 1 |
| Hori, H; Kono, T; Tanaka, H; Tayama, E; Ueda, T; Yamaki, Y | 1 |
| Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N | 1 |
| Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T | 1 |
| Fukunami, M; Hori, M; Izumi, T; Matsuzaki, M | 2 |
| Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y | 1 |
| Hirayama, A; Hori, M; Inomata, T; Izumi, T; Matsuzaki, M | 1 |
| Bilsker, M; Hauptman, PJ; Konstam, MA; O'Brien, T; Orlandi, C; Sequeira, R; Thomas, I; Udelson, JE; Zimmer, C | 1 |
| Bai, H; Li, L; Zhu, WL | 1 |
| Dohi, K; Hoshino, K; Ichikawa, K; Ito, M; Kumagai, N; Machida, H; Nakajima, H; Nakamori, S; Nakamura, M; Nobori, T; Okamoto, S; Onishi, K; Sato, Y; Sugimoto, T; Sugiura, E; Watanabe, K; Yamada, T | 1 |
| Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M | 1 |
| Burnett, JC; Demets, D; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, A; Orlandi, C; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Burnett, JC; Cook, T; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, AP; Orlandi, C; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
4 review(s) available for tolvaptan and Body Weight
| Article | Year |
|---|---|
Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial.
Topics: Antidiuretic Hormone Receptor Antagonists; Body Weight; Chronic Disease; Heart Failure; Humans; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Sodium; Tolvaptan; Urine | 2019 |
Predictors of tolvaptan short-term response in patients with refractory ascites: A meta-analysis.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Blood Urea Nitrogen; Body Weight; C-Reactive Protein; Forecasting; Hepatitis C; Humans; Time Factors; Tolvaptan | 2020 |
The short-term and long-term effects of tolvaptan in patients with heart failure: a meta-analysis of randomized controlled trials.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Creatinine; Heart Failure; Humans; Hyponatremia; Potassium; Randomized Controlled Trials as Topic; Sodium; Time Factors; Tolvaptan | 2015 |
Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Heart Failure; Humans; Mortality; Randomized Controlled Trials as Topic; Tolvaptan | 2016 |
23 trial(s) available for tolvaptan and Body Weight
| Article | Year |
|---|---|
Efficacy and safety of intravenous OPC-61815 compared with oral tolvaptan in patients with congestive heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Diuretics; Female; Heart Failure; Humans; Hyperkalemia; Male; Tolvaptan | 2022 |
Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
Topics: Aged; Aged, 80 and over; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Tolvaptan | 2020 |
Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Body Weight; Female; Humans; Male; Tolvaptan; Treatment Outcome | 2021 |
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Body Height; Body Mass Index; Body Weight; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Organ Size; Osmolar Concentration; Polycystic Kidney, Autosomal Dominant; Sex Factors; Tolvaptan; Urine | 2021 |
Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Tolvaptan; Treatment Outcome | 2017 |
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial.
Topics: Abdomen; Adolescent; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Sodium; Tolvaptan; Urine; Young Adult | 2018 |
Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? - Results of a Single-Center Randomized Controlled Study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiac Surgical Procedures; Creatinine; Diuretics; Drug Therapy, Combination; Female; Humans; Kidney; Male; Middle Aged; Postoperative Period; Tolvaptan | 2018 |
A selective oral vasopressin V2-receptor antagonist for patients with end-stage liver disease awaiting liver transplantation: a preliminary study.
Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Body Weight; Creatinine; Diuretics; End Stage Liver Disease; Female; Humans; Liver Transplantation; Male; Middle Aged; Receptors, Vasopressin; Sodium; Tolvaptan | 2019 |
Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis.
Topics: Aged; Aged, 80 and over; Ascites; Body Weight; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Humans; Japan; Liver Cirrhosis; Male; Middle Aged; Tolvaptan | 2020 |
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
Topics: Aged; Ascites; Benzazepines; Body Weight; Diuretics; Drug Administration Schedule; Edema; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Protective Agents; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Predictive factors of the pharmacological action of tolvaptan in patients with liver cirrhosis: a post hoc analysis.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Blood Urea Nitrogen; Body Weight; Female; Humans; Japan; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Tolvaptan; Urine | 2017 |
Effects of short-term administration of tolvaptan after open heart surgery.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Cardiac Surgical Procedures; Diuretics; Drug Monitoring; Drug Therapy, Combination; Female; Fluid Shifts; Furosemide; Humans; Male; Middle Aged; Postoperative Complications; Spironolactone; Tolvaptan; Treatment Outcome; Urinalysis | 2016 |
Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Creatinine; Female; Heart Failure; Humans; Japan; Kidney; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2017 |
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Dose-Response Relationship, Drug; Edema; Female; Furosemide; Humans; Japan; Liver Cirrhosis; Lower Extremity; Male; Middle Aged; Tolvaptan; Treatment Outcome; Waist Circumference | 2010 |
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Sodium; Tolvaptan; Young Adult | 2011 |
Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Sodium; Tolvaptan | 2011 |
Efficacy and safety of tolvaptan in heart failure patients with sustained volume overload despite the use of conventional diuretics: a phase III open-label study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Blood Urea Nitrogen; Body Weight; Creatinine; Diuretics; Edema, Cardiac; Female; Heart Failure; Humans; Male; Potassium; Sodium; Tolvaptan | 2011 |
Phase III clinical pharmacology study of tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Calcium; Creatinine; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema, Cardiac; Female; Furosemide; Humans; Magnesium; Male; Middle Aged; Potassium; Sodium; Tolvaptan; Uric Acid | 2011 |
A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Heart Failure, Systolic; Humans; Male; Middle Aged; Statistics as Topic; Stroke Volume; Tolvaptan; Vasopressins; Ventricular Function, Left | 2011 |
[The efficacy and safety of tolvaptan on treating heart failure patients with hyponatremia].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Sodium; Tolvaptan | 2011 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Chronic Disease; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Sodium; Tolvaptan; Treatment Outcome; Urinalysis; Water-Electrolyte Balance | 2003 |
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Double-Blind Method; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypokalemia; Placebos; Quality of Life; Research Design; Stroke Volume; Survival Rate; Tolvaptan; Treatment Outcome; Urination; Ventricular Dysfunction, Left | 2005 |
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Body Weight; Cardiovascular Agents; Creatinine; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Quality of Life; Sodium; Tolvaptan | 2007 |
16 other study(ies) available for tolvaptan and Body Weight
| Article | Year |
|---|---|
Identifying the main predictors of urine output in autosomal-dominant polycystic kidney disease (ADPKD) patients taking tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Body Weight; Creatinine; Glomerular Filtration Rate; Humans; Kidney; Male; Polycystic Kidney, Autosomal Dominant; Tolvaptan | 2023 |
Effect of early administration of tolvaptan on pleural effusion post-hepatectomy.
Topics: Body Weight; Hepatectomy; Humans; Pleural Effusion; Risk Factors; Tolvaptan | 2023 |
Efficacy and safety of tolvaptan after pediatric congenital heart disease surgery.
Topics: Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiac Surgical Procedures; Female; Heart Defects, Congenital; Humans; Infant; Male; Postoperative Complications; Retrospective Studies; Tolvaptan; Treatment Outcome | 2021 |
[Retrospective Observational Study on Predictors of Body Weight and BNP Teduction in Cases of Tolvaptan Induction for Heart Failure].
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Body Weight; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Retrospective Studies; ROC Curve; Sodium; Tolvaptan | 2021 |
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Diuretics; Female; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Potassium; Sodium; Tolvaptan; Treatment Outcome; Weight Loss | 2017 |
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; Carcinoma, Hepatocellular; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Furosemide; Humans; Liver; Liver Failure; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Spironolactone; Tolvaptan; Treatment Outcome | 2017 |
Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectiveness.
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Chlorine; Dose-Response Relationship, Drug; Hospitalization; Humans; Hyponatremia; Male; Retrospective Studies; Sodium; Time Factors; Tolvaptan | 2017 |
Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Republic of Korea; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2018 |
Impact of continued administration of tolvaptan on cirrhotic patients with ascites.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Antidiuretic Hormone Receptor Antagonists; Ascites; Body Weight; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Serum Albumin; Tolvaptan; Treatment Outcome; Young Adult | 2018 |
First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery.
Topics: Airway Management; Antidiuretic Hormone Receptor Antagonists; Blood Transfusion; Body Weight; Capillary Leak Syndrome; Cardiac Surgical Procedures; Diuretics; Female; Fluid Therapy; Humans; Infant; Infant, Newborn; Liver; Male; Osmoregulation; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Urination | 2019 |
Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Chylothorax; Female; Heart Failure; Humans; Hyponatremia; Infant, Newborn; Male; Radiography, Thoracic; Tolvaptan; Transposition of Great Vessels | 2015 |
[Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Humans; Male; Pericarditis, Constrictive; Pleural Effusion; Preoperative Care; Tolvaptan; Tomography, X-Ray Computed | 2016 |
A Safety and Efficacy Study of Tolvaptan Following Open Heart Surgery in 109 Cases.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Cardiac Surgical Procedures; Female; Heart Failure; Humans; Male; Postoperative Care; Retrospective Studies; Tolvaptan; Treatment Outcome | 2016 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Body Weight; Chlorides; Disease Models, Animal; Diuretics; Dogs; Furosemide; Heart Failure; Kidney; Male; Potassium; Renin; Sodium; Tolvaptan | 2011 |
Short-term effects of low-dose tolvaptan on hemodynamic parameters in patients with chronic heart failure.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Fluids; Body Weight; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Sodium Chloride Symporter Inhibitors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Urine; Vascular Resistance | 2012 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Creatinine; Diuretics; Echocardiography; Furosemide; Heart Failure; Heart Rate; Male; Organ Size; Osmolar Concentration; Potassium; Rats; Rats, Inbred Lew; Renin; Sodium; Tolvaptan; Ventricular Remodeling | 2008 |